SeaStar Medical Holding Corporation (NASDAQ:ICU) Short Interest Update

SeaStar Medical Holding Corporation (NASDAQ:ICU) was the target of a significant increase in short interest in March. As of March 31st, there was short interest totaling 215,212 shares, an increase of 28.1% from the March 15th total of 167,946 shares. Currently, 5.4% of the company’s stock are short sold. Based on an average trading volume of 318,775 shares, the days-to-cover ratio is currently 0.7 days.

Analyst Upgrades and Downgrades

ICU has been the topic of several research analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of SeaStar Medical in a research note on Thursday, January 22nd. Wall Street Zen raised shares of SeaStar Medical to a “hold” rating in a research note on Saturday, January 10th. Finally, Maxim Group set a $6.00 price objective on shares of SeaStar Medical in a research note on Thursday, February 12th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell” and a consensus target price of $6.00.

SeaStar Medical Price Performance

ICU opened at $3.86 on Thursday. SeaStar Medical has a fifty-two week low of $2.07 and a fifty-two week high of $13.40. The company’s 50-day moving average is $2.88 and its 200 day moving average is $3.55. The firm has a market capitalization of $15.42 million, a P/E ratio of -0.47 and a beta of -1.21.

SeaStar Medical (NASDAQ:ICU) last posted its quarterly earnings data on Wednesday, March 25th. The company reported ($0.80) EPS for the quarter, beating the consensus estimate of ($0.97) by $0.17. SeaStar Medical had a negative net margin of 984.60% and a negative return on equity of 188.47%. The firm had revenue of $0.42 million during the quarter, compared to analyst estimates of $0.22 million.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Millennium Management LLC purchased a new stake in shares of SeaStar Medical during the 3rd quarter valued at $102,000. Jane Street Group LLC purchased a new position in shares of SeaStar Medical in the 4th quarter worth about $30,000. XTX Topco Ltd grew its position in SeaStar Medical by 395.4% during the second quarter. XTX Topco Ltd now owns 60,983 shares of the company’s stock valued at $26,000 after buying an additional 48,674 shares during the period. Finally, Trinity Financial Advisors LLC grew its position in SeaStar Medical by 233.3% during the third quarter. Trinity Financial Advisors LLC now owns 50,000 shares of the company’s stock valued at $28,000 after buying an additional 35,000 shares during the period. Institutional investors own 1.69% of the company’s stock.

About SeaStar Medical

SeaStar Medical, Inc (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR.